NLS Pharmaceutics Ltd. (NASDAQ: NLSP)
$0.20
-0.0043 ( -2.10% ) 515.8K
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.
Market Data
Open
$0.20
Previous close
$0.21
Volume
515.8K
Market cap
$9.48M
Day range
$0.20 - $0.21
52 week range
$0.11 - $1.21
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
20-f | Annual reports | 98 | May 15, 2024 |
6-k | Quarterly Reports | 3 | May 14, 2024 |
nt | Quarterly Reports | 1 | Apr 30, 2024 |
6-k | Quarterly Reports | 2 | Apr 19, 2024 |
6-k | Quarterly Reports | 2 | Apr 15, 2024 |
6-k | Quarterly Reports | 1 | Apr 08, 2024 |
6-k | Quarterly Reports | 7 | Mar 21, 2024 |
6-k | Quarterly Reports | 3 | Mar 20, 2024 |
6-k | Quarterly Reports | 1 | Mar 20, 2024 |
6-k | Quarterly Reports | 3 | Mar 20, 2024 |